Background illustration for clinical trials search

Leukemia Clinical Trials

Browse 1,316 Leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

for
Acute Lymphoblastic Leukemia
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 40+

Code: NCT07400029

Phase2, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Brunswick ME, Portland ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Norfolk VA, Silver Spring MD, Fairfax VA, Durham NC,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase2, Recruiting

Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation

for
Acute Myeloid Leukemia
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: All

Age: 18+

Code: NCT07130695

Phase1, Recruiting

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

for
Leukemia, Acute Myeloid Leukemia,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 25

Code: NCT06810583

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, in Relapse,
Location: Charlottesville VA
Sponsor: Keystone Nano, Inc

Sex: All

Age: 18+

Code: NCT04716452

Phase1, Recruiting

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

for
Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL)
Location: York PA, Bethesda MD, Charlotte NC, Columbus OH,
Sponsor: Tempus AI

Sex: All

Age: 0+

Code: NCT07154823

Recruiting

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

for
Acute Myeloid Leukemia, Acute Lymphoid Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18 - 70

Code: NCT06551584

Phase1, Recruiting

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06738368

Phase2, Recruiting

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18 - 65

Code: NCT07228273

Phase2, Recruiting

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

for
CD19 Positive, Mixed Phenotype Acute Leukemia (MPAL)
Location: Morgantown WV
Sponsor: West Virginia University

Sex: All

Age: 18+

Code: NCT07222579

Phase2, Recruiting

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

for
Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia,
Location: Durham NC, Decatur IL, Houston TX
Sponsor: AstraZeneca

Sex: All

Age: 16+

Code: NCT07155226

Phase1, Phase2, Recruiting

Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

for
CLL/SLL, CLL, SLL, Chronic Lymphocytic Leukemia,
Location: Cincinnati OH
Sponsor: Zulfa Omer

Sex: All

Age: 18+

Code: NCT07108998

Phase2, Recruiting

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

for
Leukemia, Myelodysplasia, Chronic Myelomonocytic Leukemia
Location: Boston MA, Columbus OH, Birmingham AL
Sponsor: Hannah Choe, MD

Sex: All

Age: 18+

Code: NCT07249346

Phase2, Recruiting

Mosunetuzumab for CLL MRD Clearance

for
Leukemia, Chronic Lymphocytic Leukemia,
Location: Boston MA
Sponsor: Inhye Ahn

Sex: All

Age: 18+

Code: NCT07052695

Phase1, Phase2, Recruiting

Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma,
Location: Cincinnati OH
Sponsor: Zulfa Omer

Sex: All

Age: 18+

Code: NCT07014917

Phase2, Recruiting

A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.

for
Acute Leukemia, High Risk, Myelodysplastic Syndromes, High Risk,
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal

Sex: All

Age: 18 - 67

Code: NCT07301866

Phase1, Phase2, Recruiting

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

for
Recurrent Acute Myeloid Leukemia,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06871410

Phase1, Recruiting

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Scarborough ME, Boston MA
Sponsor: Inhye Ahn

Sex: All

Age: 18+

Code: NCT06333262

Phase2, Recruiting

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

for
T-cell Lymphoma, Graft Versus Host Disease, Lymphoma, T-Cell,
Location: Columbus OH
Sponsor: Jonathan Brammer

Sex: All

Age: 18+

Code: NCT07356245

Phase2, Recruiting

What are clinical trials for leukemia?

Clinical trials for leukemia are research studies designed to evaluate new treatments, therapies, or diagnostic methods for different types of leukemia, a group of cancers that affect the blood and bone marrow. These trials aim to discover more effective ways to treat leukemia, manage its symptoms, and improve patient outcomes. They may involve testing new drugs, combinations of existing treatments, targeted therapies, immunotherapies, or novel approaches like gene therapy.

Why are leukemia clinical trials important?

Leukemia clinical trials are crucial because they drive advancements in treatment by testing new therapies, improving existing ones, and exploring novel approaches to manage and potentially cure the disease. These trials provide essential data on the safety and effectiveness of new treatments, which can lead to better outcomes and fewer side effects compared to current options.

Types of clinical trials for leukemia

Why participate in a leukemia clinical trial

Who can participate in a clinical trial for leukemia?

How to enroll in a leukemia clinical trial